BIOMARIN PHARMACEUTICAL INC Contract Liability (Deferred Revenue)
BIOMARIN PHARMACEUTICAL INC (BMRN) had Contract Liability (Deferred Revenue) of $1.37 million as of 2024-12-31, per its 10-K filed 2025-02-24.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2025-02-24
- 2024-12-31: Contract with Customer, Liability, Current $1.37M.
- 2024-09-30: Contract with Customer, Liability, Current $2.35M.
- 2024-06-30: Contract with Customer, Liability, Current $1.91M.
- 2024-03-31: Contract with Customer, Liability, Current $5.15M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2024-12-31 | $1.37M 10-K · filed 2025-02-24 |
| 2024-09-30 | $2.35M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $1.91M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $5.15M 10-Q · filed 2024-04-26 |
| 2023-12-31 | $4.62M 10-K · filed 2025-02-24 |
| 2022-12-31 | $711.00K 10-K · filed 2024-02-26 |
| 2022-09-30 | $415.00K 10-Q · filed 2022-10-28 |
| 2022-06-30 | $305.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $306.00K 10-Q · filed 2022-04-29 |
| 2021-12-31 | $6.96M 10-K · filed 2023-02-27 |
| 2021-09-30 | $9.66M 10-Q · filed 2021-10-29 |
| 2021-06-30 | $11.02M 10-Q · filed 2021-07-30 |
| 2021-03-31 | $11.23M 10-Q · filed 2021-04-30 |
| 2020-12-31 | $152.00K 10-K · filed 2022-02-25 |
| 2020-09-30 | $10.93M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $5.35M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $7.89M 10-Q · filed 2020-05-01 |
| 2019-12-31 | $13.04M 10-K · filed 2021-02-26 |
| 2018-12-31 | $1.47M 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |